Traumatic Brain Injury is often called a “silent epidemic” often affecting younger patients with devasting and longlasting complications.
It is therefore great news for the medical community involved in the treatment of TBI patients when significant advances can be reported in clinical research which can improve the longterm recovery results for these patients.
Listen to highly interesting presentations about advances in neuroscience and clinical medicine in TBI care, particularly about the results of the CAPTAIN trial series and follow a panel discussion on modern TBI treatment strategies.
Peter LacknerHead of Department of Neurology, Clinic Floridsdorf, Vienna, Austria
Christian MatulaProfessor and Vice-Chairman Department of Neurosurgery, Medical University of Vienna, Austria
This webinar is hosted by
Exosomes mediate the therapeutic benefit of Cerebrolysin for TBI
by Michael Chopp
Advances in acute Neurotrauma treatment
by Christian Matula
Long-term neurocognitive consequences of TBI – The CAPTAIN-trials
by Peter Lackner